Editor
Georgiana Mihalache
- Fields
- Companies, Health, Analysis
- Writing for ZF since
- 2021
- Articles
- 226
Affidea Group Invests over EUR250M in Romania in Recent Years
Affidea, a leading player on the European and Romanian healthcare market, with a strong footprint in Romania, has invested over EUR250 million on the local market in the past four years, wit...
Jumbo Sales Rise 6% in Romania in 2025
In 2025, Romanians spent RON1.3 billion in Jumbo stores, up 6% from the previous year, in line with ZF calculations based on company data.
Thales Romania Wants to Hire 1,200 by 2030
Thales Romania now has around 800 employees locally. Plans for the next four years, until 2030, envisage heavy hiring, with the team set to reach 2,000 employees, in a context where the IT a...
AC Helcor 2025 Turnover Up 17% to RON40M YOY
Baia Mare-based drug manufacturer AC Helcor reported turnover of above RON41 million in 2025, reverting to growth of 17% year-on-year.
Medicover Absorbs Laurus Medical Four Years after Takeover
Medicover, the third largest private healthcare provider in Romania by turnover, at the end of 2025 raised the company’s share capital by RON19.5 million to complete the process of merger vi...
Antibiotice Iasi Gets 40% of Business From Exports
Antibiotice Iasi, the largest Romanian owned drug maker, has steadily boosted its exports, with 41% of turnover coming from sales abroad in 2025, namely RON266 million.
Romanian Drug Maker AC Helcor Gets EUR300,000 European Funding to Boost Exports
Romanian drug producer AC Helcor, with a plant in Baia Mare, has a EUR300,000 investment project based on EU funds via which it wants to boost its presence on foreign markets, particularly i...
Terapia Cluj Makes over EUR50M Investments in Past 5 Years
Terapia Cluj, a leading drug producer locally, has invested over EUR50 million in the past five years.
Zentiva Romania 2025 Turnover Inches Up by 0.5% YOY
Zentiva Romania group, which includes two plants in Bucharest, ended 2025 with RON1.6 billion turnover, slightly up by 0.5% from 2024.
Ropharma Group Set to Continue Development and Investment in 2026
The challenging economic context is not halting the investment plans of pharma group Ropharma, one of the biggest Romanian-held groups locally, with an integrated business.
Swiss Giant Novartis Invested $20M in Past Five Years in Targu-Mures Plant
Norvatis has pumped $20 million in its Romania drug plant of Targu-Mures in the past five years.
Pharma Group Dona Invests EUR1M in Employee Training Program
Farmaciile Dona, a top five player in the pharma sector, is readying a EUR1 million investment in own employee training and professional development.